A CT scan of the lungs produces detailed cross-sectional images that reveal nodules, masses, infections, blood clots, fluid buildup, and structural damage with far greater clarity than a standard chest X-ray. Where an X-ray gives a flat, overlapping view of the chest, CT slices through the body in thin layers, making it possible to spot abnormalities as small as a few millimeters and distinguish between conditions that look similar on simpler imaging.
How CT Compares to a Chest X-Ray
The difference in detection ability is significant. In a prospective trial comparing ultra-low-dose CT to chest X-ray in emergency department patients, CT caught 94.1% of clinically relevant findings, while X-ray detected only 62.5%. CT was also more precise at ruling out disease, with a specificity of 98.5% compared to 93.9% for X-ray. This means CT is both better at finding real problems and less likely to flag something that isn’t there.
That said, CT delivers more radiation than a plain X-ray, so it isn’t the automatic first choice for every situation. Many evaluations start with an X-ray, and CT is used when that initial image is inconclusive, when a specific diagnosis needs confirmation, or when the clinical suspicion is high enough to justify going straight to detailed imaging.
Lung Nodules and Masses
One of the most common findings on a lung CT is a pulmonary nodule, a small spot of tissue that shows up as a bright dot. CT can detect nodules smaller than 10 mm in diameter and characterize their edges, density, and location. This matters because the features of a nodule help determine whether it’s likely harmless or potentially cancerous. A nodule with smooth, regular edges in a younger person with no smoking history is far less concerning than one with irregular, spiculated edges in an upper lobe of an older smoker.
Larger masses and calcified nodules also show up clearly. Calcification patterns visible on CT help narrow the diagnosis. Some patterns are typical of benign growths like hamartomas, while others suggest malignancy. Lung cancer is diagnosed in just under 10% of patients who have a nodule larger than 8 mm, which is why size and appearance guide the follow-up plan.
What Happens When a Small Nodule Is Found
Many lung nodules are discovered incidentally, meaning the scan was done for another reason entirely. Guidelines from the Fleischner Society provide a clear framework for what comes next. A single solid nodule under 6 mm in a low-risk patient requires no follow-up at all. For nodules between 6 and 8 mm, a repeat CT in 6 to 12 months is typical. Nodules over 8 mm generally warrant closer evaluation, potentially including a PET-CT scan or biopsy. If a nodule hasn’t changed over two years of monitoring in a low-risk patient, further follow-up is usually unnecessary.
Lung Cancer Screening
Low-dose CT is the standard screening tool for lung cancer in high-risk individuals. The U.S. Preventive Services Task Force recommends annual screening for adults aged 50 to 80 who have a 20 pack-year smoking history and either currently smoke or quit within the past 15 years. A “pack-year” means smoking one pack per day for one year, so someone who smoked two packs a day for 10 years qualifies.
Low-dose CT uses less radiation than a standard diagnostic scan while still providing enough detail to catch early-stage cancers. Modern classification systems like Lung-RADS have reduced the false-positive rate to about 12.8%, down from 26.6% with earlier approaches, by raising the threshold for what counts as a suspicious nodule to 5 or 6 mm. Screening stops once someone has been smoke-free for 15 years or develops a condition that limits life expectancy.
Infections: Pneumonia, Tuberculosis, and Fungal Disease
CT reveals the specific pattern of an infection, which helps distinguish between bacterial pneumonia, tuberculosis, and fungal disease. Each leaves a different signature in the lungs.
Bacterial pneumonia typically appears as consolidation, areas where air-filled lung tissue has been replaced by fluid and inflammatory material, following the boundaries of a lung segment. Tuberculosis, by contrast, favors the upper lobes and the upper portions of the lower lobes. It produces lobular consolidation rather than segmental, and cavitation (hollow spaces within diseased tissue) is visible on CT in about 40% of active cases. Thick-walled cavities with surrounding consolidation indicate active infection, while thin, smooth-walled cavities suggest healed disease. CT can also pick up the “tree-in-bud” sign, tiny branching opacities that indicate TB has spread through the airways.
Fungal infections tend to produce large nodules surrounded by a halo of hazy opacity (called ground-glass) with internal cavitation. Air-fluid levels inside a cavity can signal that a fungal infection has developed on top of an existing cavity, which occurs in roughly 10% of cases.
Blood Clots in the Lungs
CT pulmonary angiography is the go-to test for diagnosing pulmonary embolism, a blood clot that has traveled to the lungs. This version of the scan uses intravenous contrast dye to light up the blood vessels, making clots visible as dark gaps where the dye can’t flow. The sensitivity is excellent, detecting 99.8% of pulmonary emboli in one large study of over 500 confirmed cases.
The scan can pinpoint exactly where a clot is lodged, from the main pulmonary arteries all the way down to tiny subsegmental branches. This location matters for treatment decisions, since a large central clot poses a more immediate threat than a small one at the periphery.
COPD and Emphysema
CT doesn’t just show what’s in the lungs. It also reveals what’s missing. In emphysema, the tiny air sacs that exchange oxygen are destroyed and replaced by larger, useless air spaces. On CT, these areas appear abnormally dark because they contain almost nothing but trapped air. Healthy lung tissue registers at about -850 on the scan’s density scale, while emphysematous areas drop close to -1000, which is essentially the density of pure air.
Quantitative CT can measure the percentage of lung volume that falls below a specific density threshold, giving an objective number for how much lung tissue has been destroyed. The scan can also assess air trapping by comparing images taken during a full breath in versus a full breath out. In a healthy lung, most of the air leaves on exhalation. In COPD, significant volumes of air remain trapped, and the scan captures this difference precisely. These measurements help track disease progression and evaluate whether someone might benefit from surgical or bronchoscopic procedures that target the most damaged areas.
Interstitial Lung Disease and Fibrosis
High-resolution CT is the primary imaging tool for diagnosing interstitial lung diseases, a group of conditions where the tissue between the air sacs becomes scarred or inflamed. The scan reveals specific patterns that point to different diagnoses. Reticulation, a fine net-like pattern, indicates thickening of the tissue framework. Honeycombing, clusters of small cystic spaces stacked together, signals advanced, irreversible fibrosis. Traction bronchiectasis, where scarring has pulled the airways open wider than normal, is another hallmark of fibrotic disease.
The distribution of these findings matters as much as the findings themselves. Fibrosis concentrated in the lower lobes and along the outer edges of the lungs points toward one group of diagnoses, while upper-lobe predominance suggests another. Ground-glass opacity, a hazy increase in lung density through which blood vessels are still visible, can indicate active inflammation that might respond to treatment, as opposed to established scarring that will not.
Fluid and Pleural Abnormalities
CT clearly shows fluid collections around the lungs (pleural effusions), thickening or calcification of the pleural lining, and pericardial effusions around the heart. Pleural calcification often results from long-standing inflammatory conditions like prior tuberculosis, old empyema, or previous bleeding into the chest cavity. When contrast dye is used, the scan can distinguish between simple fluid collections and more complex ones like empyema or malignant effusions, because infected or cancerous tissue enhances (brightens) with contrast while simple fluid does not.
When Contrast Dye Is Needed
Most lung CT scans do not require intravenous contrast. Evaluations for COPD, interstitial lung disease, lung nodules, airway disease, and cancer screening are all performed without it. Contrast becomes necessary when the scan needs to evaluate blood vessels, as in suspected pulmonary embolism, aortic aneurysm, or dissection. It’s also used when there’s concern about tumor invasion into the central chest structures, or when pleural disease needs further characterization. A non-contrast scan is sometimes done first to identify calcifications or bleeding, followed by a contrast-enhanced scan to complete the picture.